Bayforest Capital’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$151K Buy
7,274
+104
+1% +$2.45K 0.14% 264
2026
Q1
$163K Sell
7,170
-4,177
-37% -$98.7K 0.18% 186
2025
Q4
$302K Buy
+11,347
New +$335K 0.23% 130
2025
Q3
Sell
-146
Closed -$4.58K 786
2025
Q2
$4.58K Buy
146
+133
+1,023% +$4.4K ﹤0.01% 672
2025
Q1
$497 Buy
+13
New +$552 ﹤0.01% 710

Other funds holding ENOV

Bayforest Capital's ENOV Position: Q2 2026 in Review

Bayforest Capital increased its Enovis (ENOV) stake by 1.5% in Q2 2026, buying an estimated $2.45K and bringing the position to 7,274 shares worth $151K. The position accounts for 0.14% of the portfolio, ranked #264.

Bayforest Capital first reported a position in ENOV in Q1 2025 and has held it in 5 quarters since. The position peaked at $302K in Q4 2025. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Bayforest Capital held 7,274 shares of Enovis worth $151K as of Q2 2026.
  • Bayforest Capital bought 104 Enovis shares in Q2 2026, an estimated $2.45K.
  • Enovis made up 0.14% of Bayforest Capital's portfolio in Q2 2026, its #264 holding.
  • Bayforest Capital first reported a position in Enovis in Q1 2025 and has held it in 5 quarters since.
  • Bayforest Capital's Enovis position peaked at $302K in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.